News Articles Tagged: Cardiorenal Treatment

Canagliflozin in Type 2 Diabetes: Dosage, Administration, and Clinical Efficacy

A practical guide to Canagliflozin's dosage, administration, and proven efficacy in managing type 2 diabetes, including its benefits for cardiovascular and kidney health. Learn from NINGBO INNO PHARMCHEM CO.,LTD.

The Clinical Impact of Finerenone: From Trial Data to Treatment Guidelines

Analyze the clinical evidence supporting Finerenone's use, its journey from pivotal trials to its incorporation into treatment guidelines for managing cardiorenal diseases in patients with T2DM and CKD.

Finerenone vs. Steroidal MRAs: Understanding the Differences in Cardiorenal Treatment

Compare Finerenone with traditional steroidal mineralocorticoid receptor antagonists (MRAs), highlighting key differences in selectivity, efficacy, safety profile, and clinical applications for cardiorenal diseases.